Strategies to facilitate or block nose-to-brain drug delivery
Display Omitted
Gespeichert in:
| Autor*in: |
Martins, Patricia P. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:570 ; year:2019 ; day:30 ; month:10 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2019.118635 |
|---|
| Katalog-ID: |
ELV048040924 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV048040924 | ||
| 003 | DE-627 | ||
| 005 | 20230624142519.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2019.118635 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000761.pica |
| 035 | |a (DE-627)ELV048040924 | ||
| 035 | |a (ELSEVIER)S0378-5173(19)30680-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Martins, Patricia P. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Strategies to facilitate or block nose-to-brain drug delivery |
| 264 | 1 | |c 2019 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Intranasal |2 Elsevier | |
| 650 | 7 | |a Local delivery |2 Elsevier | |
| 650 | 7 | |a Brain delivery |2 Elsevier | |
| 650 | 7 | |a Systemic delivery |2 Elsevier | |
| 650 | 7 | |a Devices |2 Elsevier | |
| 700 | 1 | |a Smyth, Hugh D.C. |4 oth | |
| 700 | 1 | |a Cui, Zhengrong |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:570 |g year:2019 |g day:30 |g month:10 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2019.118635 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 570 |j 2019 |b 30 |c 1030 |h 0 | ||
| author_variant |
p p m pp ppm |
|---|---|
| matchkey_str |
martinspatriciapsmythhughdccuizhengrong:2019----:taeisoaiiaerlcnstba |
| hierarchy_sort_str |
2019 |
| bklnumber |
44.61 |
| publishDate |
2019 |
| allfields |
10.1016/j.ijpharm.2019.118635 doi GBV00000000000761.pica (DE-627)ELV048040924 (ELSEVIER)S0378-5173(19)30680-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Martins, Patricia P. verfasserin aut Strategies to facilitate or block nose-to-brain drug delivery 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Elsevier Smyth, Hugh D.C. oth Cui, Zhengrong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:570 year:2019 day:30 month:10 pages:0 https://doi.org/10.1016/j.ijpharm.2019.118635 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 570 2019 30 1030 0 |
| spelling |
10.1016/j.ijpharm.2019.118635 doi GBV00000000000761.pica (DE-627)ELV048040924 (ELSEVIER)S0378-5173(19)30680-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Martins, Patricia P. verfasserin aut Strategies to facilitate or block nose-to-brain drug delivery 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Elsevier Smyth, Hugh D.C. oth Cui, Zhengrong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:570 year:2019 day:30 month:10 pages:0 https://doi.org/10.1016/j.ijpharm.2019.118635 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 570 2019 30 1030 0 |
| allfields_unstemmed |
10.1016/j.ijpharm.2019.118635 doi GBV00000000000761.pica (DE-627)ELV048040924 (ELSEVIER)S0378-5173(19)30680-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Martins, Patricia P. verfasserin aut Strategies to facilitate or block nose-to-brain drug delivery 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Elsevier Smyth, Hugh D.C. oth Cui, Zhengrong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:570 year:2019 day:30 month:10 pages:0 https://doi.org/10.1016/j.ijpharm.2019.118635 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 570 2019 30 1030 0 |
| allfieldsGer |
10.1016/j.ijpharm.2019.118635 doi GBV00000000000761.pica (DE-627)ELV048040924 (ELSEVIER)S0378-5173(19)30680-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Martins, Patricia P. verfasserin aut Strategies to facilitate or block nose-to-brain drug delivery 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Elsevier Smyth, Hugh D.C. oth Cui, Zhengrong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:570 year:2019 day:30 month:10 pages:0 https://doi.org/10.1016/j.ijpharm.2019.118635 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 570 2019 30 1030 0 |
| allfieldsSound |
10.1016/j.ijpharm.2019.118635 doi GBV00000000000761.pica (DE-627)ELV048040924 (ELSEVIER)S0378-5173(19)30680-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Martins, Patricia P. verfasserin aut Strategies to facilitate or block nose-to-brain drug delivery 2019 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Elsevier Smyth, Hugh D.C. oth Cui, Zhengrong oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:570 year:2019 day:30 month:10 pages:0 https://doi.org/10.1016/j.ijpharm.2019.118635 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 570 2019 30 1030 0 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:570 year:2019 day:30 month:10 pages:0 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:570 year:2019 day:30 month:10 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Intranasal Local delivery Brain delivery Systemic delivery Devices |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Martins, Patricia P. @@aut@@ Smyth, Hugh D.C. @@oth@@ Cui, Zhengrong @@oth@@ |
| publishDateDaySort_date |
2019-01-30T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV048040924 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048040924</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142519.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2019.118635</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000761.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048040924</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(19)30680-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Martins, Patricia P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strategies to facilitate or block nose-to-brain drug delivery</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intranasal</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Brain delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Systemic delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Devices</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smyth, Hugh D.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cui, Zhengrong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:570</subfield><subfield code="g">year:2019</subfield><subfield code="g">day:30</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2019.118635</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">570</subfield><subfield code="j">2019</subfield><subfield code="b">30</subfield><subfield code="c">1030</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Martins, Patricia P. |
| spellingShingle |
Martins, Patricia P. ddc 610 bkl 44.61 Elsevier Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Strategies to facilitate or block nose-to-brain drug delivery |
| authorStr |
Martins, Patricia P. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.61 bkl Strategies to facilitate or block nose-to-brain drug delivery Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Intranasal Elsevier Local delivery Elsevier Brain delivery Elsevier Systemic delivery Elsevier Devices |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h d s hd hds z c zc |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Strategies to facilitate or block nose-to-brain drug delivery |
| ctrlnum |
(DE-627)ELV048040924 (ELSEVIER)S0378-5173(19)30680-5 |
| title_full |
Strategies to facilitate or block nose-to-brain drug delivery |
| author_sort |
Martins, Patricia P. |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Martins, Patricia P. |
| container_volume |
570 |
| class |
610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Martins, Patricia P. |
| doi_str_mv |
10.1016/j.ijpharm.2019.118635 |
| dewey-full |
610 |
| title_sort |
strategies to facilitate or block nose-to-brain drug delivery |
| title_auth |
Strategies to facilitate or block nose-to-brain drug delivery |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Strategies to facilitate or block nose-to-brain drug delivery |
| url |
https://doi.org/10.1016/j.ijpharm.2019.118635 |
| remote_bool |
true |
| author2 |
Smyth, Hugh D.C. Cui, Zhengrong |
| author2Str |
Smyth, Hugh D.C. Cui, Zhengrong |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.ijpharm.2019.118635 |
| up_date |
2024-07-06T17:48:08.860Z |
| _version_ |
1803852803065511936 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048040924</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142519.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2019.118635</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000761.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048040924</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(19)30680-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Martins, Patricia P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strategies to facilitate or block nose-to-brain drug delivery</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intranasal</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Brain delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Systemic delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Devices</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smyth, Hugh D.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cui, Zhengrong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:570</subfield><subfield code="g">year:2019</subfield><subfield code="g">day:30</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2019.118635</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">570</subfield><subfield code="j">2019</subfield><subfield code="b">30</subfield><subfield code="c">1030</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4018297 |